Extended release pharmaceutical compositions of divalproex sodium
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- RANBAXY LAB LTD
- Publication Date
- 2007-02-28
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The present invention relates to sustained-release preparations comprising valproic acid, and pharmaceutically acceptable salts, esters or amides thereof or divalproex sodium (divalproex sodium) and a preparation method thereof. Background of the invention
[0002] Valproic acid, 2-valproic acid and their derivatives are widely used in the treatment of mania, migraine and epilepsy. These compounds dissociate into the valproate ion in the gastrointestinal tract.
[0003] Several physical properties of valproic acid and its derivatives make formulation into dosage forms problematic. They are liquid or liquefy rapidly and are viscous. Also by nature, most valproic acid and its derivatives are extremely hygroscopic. These physicochemical properties of valproic acid and its derivatives present serious problems in the manufacture of pharmaceutical compositions.
[0004] In addition, valproic acid and its derivatives have short elimination half-lives. Fo...